Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Three Grand Openings next few weeks W/7 more before end of year and Florida voters (me) going to polls in November.. LOL $$$$$$$$$
$$$VPOR$$$$
ST 1.3 strong
porky, these numbers looking a little better? LOL
We have not seen anything yet..
slow and steady..
ST1.3 long
Where is the porkster on the fun days? LOL
Under Fundamentals at TD Ameritrade as of last filling
Share Information
VPOR is in a share class of CS
Float 93.2M
Shares Outstanding 334.4M
Institutions Holding Shares --
Held By Institutions --
A/S is 2B
spshond, If Vapor was to buy back 100m of the float there would be a share deficit of 6.8m that would make all our shares Naked Shorts plus the 6.8m of the buy back. There is only 93.2M in the float minus 1.3M I hold... LOL
As far as pay off the loan, I believe that needs to be done with in 6 months of agreement date which would be nice, then cancel the shares of that note.
ST
MMJ on ballot in November.. It will pass.....CBD passed the last week or two..........Florida CBD done...........next MMJ.
Even near my town the city council have set 3 locations for MMJ dispensaries...
I think August my self, wife/son/and my B-Day month... LOL
It will be like, "Happy Birth Day To Me" and you know how the rest of it goes..LOL
ST
TSP540, I asked the same question in a Email to Michelle, did not get a Y/N answer but the response was (MMJ/MJ is still illegal in Florida) with that being said, I personally am of the belief that until the November vote in Florida passes, we will not know for sure about any dispensary plans. Do remember that Vapor will be at WeedStock next week. So I again would have to believe there is or could be the opportunity to have 10 to 30 store fronts set up threw out Florida ready for when the opportunity comes to permit for a dispensary license...
Read some of my past posts for more of my opinion in reference to this subject.
Hope this will answer your question.
ST 1.3M long
BIGdaddyLONGstrokes, porky has been here as a long since 02/20/2014. porky has brought some great DD to this board. Remember what your parents taught you, If you do not have nothing nice to say then do not say anything......Thank you
ST 1.3m long
Wow some one here must be in deep pooo whit there shorts. Margin calls are a bitch..... Lol
Nothing has happened to porky that has not happened to most of the longs here at least one time or another. It rely does get frustrating once in awhile. What a roller coaster this whole sector has been since Jan..
By the way, great DD there porky.
Thanks again,
ST 1.3M long
M.J. RE-CLASSIFICATION GETTING CLOSER-
FDA To Evaluate Marijuana For Potential Reclassification As Less Dangerous Drug
Posted: 06/24/2014 6:44 pm EDT
The feds could actually soften their stance a little when it comes to weed.
The Food and Drug Administration is reviewing the medical evidence surrounding the safety and effectiveness of marijuana, a process that could lead to the agency downgrading the drug's current status as a Schedule I drug, the most dangerous classification.
FDA Press Officer Jeff Ventura described the review process, which is being completed at the request of the Drug Enforcement Agency, to The Huffington Post.
"FDA conducts for Health and Human Services a scientific and medical analysis of the drug under consideration, which is currently ongoing," Ventura said. "HHS then recommends to DEA that the drug be placed in a given schedule. DEA considers HHS’ analysis, conducts its own assessment, and makes a final scheduling proposal in the form of a proposed rule."
The FDA could not confirm how long the review process would take.
The U.S. has five "schedules" for drugs or chemicals that can be used to make drugs. Schedule I is reserved for drugs that the DEA considers to have the highest potential for abuse and no "current accepted medical use." Marijuana has been classified as Schedule I for decades, along with other substances like heroin and LSD. Rescheduling marijuana would not make it legal, but a lower schedule could potentially ease restrictions on research into the drug and make banks less wary of offering financial services to state-legal marijuana businesses. It could also allow those businesses to make some traditional tax deductions.
"While DEA is the lead federal agency responsible for regulating controlled substances and enforcing the Controlled Substances Act, FDA, working with NIDA, provides scientific recommendations about the appropriate controls for those substances," FDA Deputy Director Doug Throckmorton said Friday in testimony delivered during the House Committee on Oversight and Government Reform hearing.
"To make these recommendations, FDA is responsible for preparing what's called an eight-factor analysis, which is a document that is used to assess how likely a drug is to be abused," Throckmorton said.
Here are the eight factors the FDA will consider about marijuana when deciding which schedule it should go under, according to the CSA:
1. Its actual or relative potential for abuse
2. Scientific evidence of its pharmacological effect, if known
3. The state of current scientific knowledge regarding the drug or other substance
4. Its history and current pattern of abuse
5. The scope, duration, and significance of abuse
6. What, if any, risk there is to the public health
7. Its psychic or physiological dependence liability
8. Whether the substance is an immediate precursor of a substance already controlled under this subchapter
A DEA spokeswoman told HuffPost that the agency was required to order the FDA to review marijuana's scheduling status because of two public citizens' petitions that asked the agency for a review. A change could put marijuana in the company of cocaine and methamphetamine, two other Schedule II drugs.
This isn't the first time the DEA has asked the FDA to reconsider marijuana, Throckmorton said Friday. In 2001 and 2006, the DEA requested an analysis of the drug after receiving other public petitions requesting that the agency reschedule it. But both times, federal regulators determined that marijuana should remain a Schedule I substance. At the time, the FDA said there simply wasn't enough research about marijuana's efficacy in treating various ailments.
Part of the lack of cannabis science in the U.S. has to do with the federal stranglehold on marijuana research. There's only one federally legal marijuana garden in the U.S., at the University of Mississippi. The National Institute on Drug Abuse oversees the operation, and it's the only source of marijuana for federally sanctioned studies on the drug.
To date, NIDA has conducted about 30 studies on the potential benefits of marijuana. Since 2003, it has approved more than 500 grants for marijuana-related studies, with a marked upswing in recent years, according to McClatchy. In 2003, 22 grants totaling $6 million were approved for cannabis research, McClatchy reported. In 2012, that number had risen to 69 approved grants totaling more than $30 million.
Federal authorities have long been accused of only funding marijuana research that focuses on the potential negative effects of the substance. The DEA has also been accused of not acting quickly enough when petitioned to reschedule marijuana, and for obstructing science around the drug.
Meanwhile, a number of recent studies have added to the growing body of research showing the medical potential of cannabis. Purified forms may attack some forms of aggressive cancer. Studies have tied marijuana use to blood sugar control and slowing the spread of HIV. One study found that legalization of the plant for medical purposes may even lead to lower suicide rates.
Currently, 22 states and the District of Columbia have legalized marijuana for medical use, with New York state poised to be the 23rd. About ten other states have also legalized CBD-oil, a non-psychoactive ingredient in marijuana frequently used to treat epilepsy, for research or limited medical purposes.
According to a recent CBS News poll, a vast majority of Americans -- over 80 percent -- approve of medical marijuana legalization.
While the FDA isn't ready to get on board with legalization, it does seem more interested in the medical benefits of the drug.
"The FDA has not approved marijuana as a safe and effective drug for any indication," the FDA stated in its latest guidelines regarding marijuana, posted Friday. "The FDA is aware that there is considerable interest in its use to attempt to treat a number of medical conditions, including, for example, glaucoma, AIDS wasting syndrome, neuropathic pain, cancer, multiple sclerosis, chemotherapy-induced nausea, and certain seizure disorders."
M.J. RE-CLASSIFICATION GETTING CLOSER-
FDA To Evaluate Marijuana For Potential Reclassification As Less Dangerous Drug
Posted: 06/24/2014 6:44 pm EDT
The feds could actually soften their stance a little when it comes to weed.
The Food and Drug Administration is reviewing the medical evidence surrounding the safety and effectiveness of marijuana, a process that could lead to the agency downgrading the drug's current status as a Schedule I drug, the most dangerous classification.
FDA Press Officer Jeff Ventura described the review process, which is being completed at the request of the Drug Enforcement Agency, to The Huffington Post.
"FDA conducts for Health and Human Services a scientific and medical analysis of the drug under consideration, which is currently ongoing," Ventura said. "HHS then recommends to DEA that the drug be placed in a given schedule. DEA considers HHS’ analysis, conducts its own assessment, and makes a final scheduling proposal in the form of a proposed rule."
The FDA could not confirm how long the review process would take.
The U.S. has five "schedules" for drugs or chemicals that can be used to make drugs. Schedule I is reserved for drugs that the DEA considers to have the highest potential for abuse and no "current accepted medical use." Marijuana has been classified as Schedule I for decades, along with other substances like heroin and LSD. Rescheduling marijuana would not make it legal, but a lower schedule could potentially ease restrictions on research into the drug and make banks less wary of offering financial services to state-legal marijuana businesses. It could also allow those businesses to make some traditional tax deductions.
"While DEA is the lead federal agency responsible for regulating controlled substances and enforcing the Controlled Substances Act, FDA, working with NIDA, provides scientific recommendations about the appropriate controls for those substances," FDA Deputy Director Doug Throckmorton said Friday in testimony delivered during the House Committee on Oversight and Government Reform hearing.
"To make these recommendations, FDA is responsible for preparing what's called an eight-factor analysis, which is a document that is used to assess how likely a drug is to be abused," Throckmorton said.
Here are the eight factors the FDA will consider about marijuana when deciding which schedule it should go under, according to the CSA:
1. Its actual or relative potential for abuse
2. Scientific evidence of its pharmacological effect, if known
3. The state of current scientific knowledge regarding the drug or other substance
4. Its history and current pattern of abuse
5. The scope, duration, and significance of abuse
6. What, if any, risk there is to the public health
7. Its psychic or physiological dependence liability
8. Whether the substance is an immediate precursor of a substance already controlled under this subchapter
A DEA spokeswoman told HuffPost that the agency was required to order the FDA to review marijuana's scheduling status because of two public citizens' petitions that asked the agency for a review. A change could put marijuana in the company of cocaine and methamphetamine, two other Schedule II drugs.
This isn't the first time the DEA has asked the FDA to reconsider marijuana, Throckmorton said Friday. In 2001 and 2006, the DEA requested an analysis of the drug after receiving other public petitions requesting that the agency reschedule it. But both times, federal regulators determined that marijuana should remain a Schedule I substance. At the time, the FDA said there simply wasn't enough research about marijuana's efficacy in treating various ailments.
Part of the lack of cannabis science in the U.S. has to do with the federal stranglehold on marijuana research. There's only one federally legal marijuana garden in the U.S., at the University of Mississippi. The National Institute on Drug Abuse oversees the operation, and it's the only source of marijuana for federally sanctioned studies on the drug.
To date, NIDA has conducted about 30 studies on the potential benefits of marijuana. Since 2003, it has approved more than 500 grants for marijuana-related studies, with a marked upswing in recent years, according to McClatchy. In 2003, 22 grants totaling $6 million were approved for cannabis research, McClatchy reported. In 2012, that number had risen to 69 approved grants totaling more than $30 million.
Federal authorities have long been accused of only funding marijuana research that focuses on the potential negative effects of the substance. The DEA has also been accused of not acting quickly enough when petitioned to reschedule marijuana, and for obstructing science around the drug.
Meanwhile, a number of recent studies have added to the growing body of research showing the medical potential of cannabis. Purified forms may attack some forms of aggressive cancer. Studies have tied marijuana use to blood sugar control and slowing the spread of HIV. One study found that legalization of the plant for medical purposes may even lead to lower suicide rates.
Currently, 22 states and the District of Columbia have legalized marijuana for medical use, with New York state poised to be the 23rd. About ten other states have also legalized CBD-oil, a non-psychoactive ingredient in marijuana frequently used to treat epilepsy, for research or limited medical purposes.
According to a recent CBS News poll, a vast majority of Americans -- over 80 percent -- approve of medical marijuana legalization.
While the FDA isn't ready to get on board with legalization, it does seem more interested in the medical benefits of the drug.
"The FDA has not approved marijuana as a safe and effective drug for any indication," the FDA stated in its latest guidelines regarding marijuana, posted Friday. "The FDA is aware that there is considerable interest in its use to attempt to treat a number of medical conditions, including, for example, glaucoma, AIDS wasting syndrome, neuropathic pain, cancer, multiple sclerosis, chemotherapy-induced nausea, and certain seizure disorders."
M.J. RE-CLASSIFICATION GETTING CLOSER-
FDA To Evaluate Marijuana For Potential Reclassification As Less Dangerous Drug
Posted: 06/24/2014 6:44 pm EDT
The feds could actually soften their stance a little when it comes to weed.
The Food and Drug Administration is reviewing the medical evidence surrounding the safety and effectiveness of marijuana, a process that could lead to the agency downgrading the drug's current status as a Schedule I drug, the most dangerous classification.
FDA Press Officer Jeff Ventura described the review process, which is being completed at the request of the Drug Enforcement Agency, to The Huffington Post.
"FDA conducts for Health and Human Services a scientific and medical analysis of the drug under consideration, which is currently ongoing," Ventura said. "HHS then recommends to DEA that the drug be placed in a given schedule. DEA considers HHS’ analysis, conducts its own assessment, and makes a final scheduling proposal in the form of a proposed rule."
The FDA could not confirm how long the review process would take.
The U.S. has five "schedules" for drugs or chemicals that can be used to make drugs. Schedule I is reserved for drugs that the DEA considers to have the highest potential for abuse and no "current accepted medical use." Marijuana has been classified as Schedule I for decades, along with other substances like heroin and LSD. Rescheduling marijuana would not make it legal, but a lower schedule could potentially ease restrictions on research into the drug and make banks less wary of offering financial services to state-legal marijuana businesses. It could also allow those businesses to make some traditional tax deductions.
"While DEA is the lead federal agency responsible for regulating controlled substances and enforcing the Controlled Substances Act, FDA, working with NIDA, provides scientific recommendations about the appropriate controls for those substances," FDA Deputy Director Doug Throckmorton said Friday in testimony delivered during the House Committee on Oversight and Government Reform hearing.
"To make these recommendations, FDA is responsible for preparing what's called an eight-factor analysis, which is a document that is used to assess how likely a drug is to be abused," Throckmorton said.
Here are the eight factors the FDA will consider about marijuana when deciding which schedule it should go under, according to the CSA:
1. Its actual or relative potential for abuse
2. Scientific evidence of its pharmacological effect, if known
3. The state of current scientific knowledge regarding the drug or other substance
4. Its history and current pattern of abuse
5. The scope, duration, and significance of abuse
6. What, if any, risk there is to the public health
7. Its psychic or physiological dependence liability
8. Whether the substance is an immediate precursor of a substance already controlled under this subchapter
A DEA spokeswoman told HuffPost that the agency was required to order the FDA to review marijuana's scheduling status because of two public citizens' petitions that asked the agency for a review. A change could put marijuana in the company of cocaine and methamphetamine, two other Schedule II drugs.
This isn't the first time the DEA has asked the FDA to reconsider marijuana, Throckmorton said Friday. In 2001 and 2006, the DEA requested an analysis of the drug after receiving other public petitions requesting that the agency reschedule it. But both times, federal regulators determined that marijuana should remain a Schedule I substance. At the time, the FDA said there simply wasn't enough research about marijuana's efficacy in treating various ailments.
Part of the lack of cannabis science in the U.S. has to do with the federal stranglehold on marijuana research. There's only one federally legal marijuana garden in the U.S., at the University of Mississippi. The National Institute on Drug Abuse oversees the operation, and it's the only source of marijuana for federally sanctioned studies on the drug.
To date, NIDA has conducted about 30 studies on the potential benefits of marijuana. Since 2003, it has approved more than 500 grants for marijuana-related studies, with a marked upswing in recent years, according to McClatchy. In 2003, 22 grants totaling $6 million were approved for cannabis research, McClatchy reported. In 2012, that number had risen to 69 approved grants totaling more than $30 million.
Federal authorities have long been accused of only funding marijuana research that focuses on the potential negative effects of the substance. The DEA has also been accused of not acting quickly enough when petitioned to reschedule marijuana, and for obstructing science around the drug.
Meanwhile, a number of recent studies have added to the growing body of research showing the medical potential of cannabis. Purified forms may attack some forms of aggressive cancer. Studies have tied marijuana use to blood sugar control and slowing the spread of HIV. One study found that legalization of the plant for medical purposes may even lead to lower suicide rates.
Currently, 22 states and the District of Columbia have legalized marijuana for medical use, with New York state poised to be the 23rd. About ten other states have also legalized CBD-oil, a non-psychoactive ingredient in marijuana frequently used to treat epilepsy, for research or limited medical purposes.
According to a recent CBS News poll, a vast majority of Americans -- over 80 percent -- approve of medical marijuana legalization.
While the FDA isn't ready to get on board with legalization, it does seem more interested in the medical benefits of the drug.
"The FDA has not approved marijuana as a safe and effective drug for any indication," the FDA stated in its latest guidelines regarding marijuana, posted Friday. "The FDA is aware that there is considerable interest in its use to attempt to treat a number of medical conditions, including, for example, glaucoma, AIDS wasting syndrome, neuropathic pain, cancer, multiple sclerosis, chemotherapy-induced nausea, and certain seizure disorders."
Great find porky... Thanks, I hope you don’t mind me posting this article in some other boards.
Thanks again.
ST 1.3 long
porky, and all of you on the fence...... Keep your eyes on the gold. This is a new company in a industry that is coming to fruition.. I can say that this is going to be HUGE with confidence due to the GOVERNMENTS involvement in it... As you know, this blood sucking GOVERNMENT will not let one RED CENT pass their greedy hands for their wall street friends. I am not saying this is the God Father of the industry, but it is a start to gaining momentum in this sector. RIDE THE WAVE Bro.... I to wish I had sold some out at .42 but there is much more to come, don't let THEM get you down........ One of the best thing any one can do in the meantime is to do any/all the due diligence of the sector and post it everywhere. Keep the momentum going forwards, there is a lot to learn and teach to all the inquisitive new investors.............Dam that was a lot for my drunk azzzzzzzzzz...... LOL
OOOOOOOWellllll..
Just a note following up on a post of mine last week, the number of friends has now risen to 12........ THANKS PILL MILL BASTARDS.........
RE:TheSittingtight1 Thursday, 06/19/14 12:37:10 PM
Re: G-OiL-D post# 30147
Post # of 30383
Quote:Medical Marijuana Sector Could Exceed $8 Billion
in Revenue
G OIL, the funny part is that this revenue has been going to the Mexican Drug Cartels/CIA for decades now. It's about time this Government gets their heads out of the azzes of the pharmaceutical company’s special interest in Washington and all State Capitols around the country.
There should be all kinds of prosecutions of these ba$tards for killing Americans with the pill mill drugs............ PISSES ME FRICKING OFF..
I personally have seen and been to 11 funerals of friends I grew up with in the past 30 years:(........................................
That's all I have to say about that..
ST w/1.3M
ST 1.3M
Porky, EXACTLY what is it that this company has not followed threw on since Jan. 22, 2014? All the fillings (done) Audited at that. Merger (done) Name/ticker change (done) R/S Cancelled (was not needed w/existing share structure). Some of this took time to get accomplished but they got it done. Q1 2014 "are you FRICKING kidding me?"
Vapor just announced the future opening of 3 store fronts is south Fl. just a few week ago, did you expect these stores just to magically appear?
Yes, the roll out of the CBD Oil apparently is slow to happen, but I have to ask you this. "What company to this day is selling CBD Oil for consumption w/a vaporizer?"
Any way, quit your girly bitching and grow some balls... If you can't take the heat, leave the kitchen.
Dam I hate getting all excited..
That is all I have to say about that..
ST 1.3 Million Going Long
new websites will reinforce the openings of our retail stores throughout Florida, of which we will have ten by year-end, reaching from Miami to Orlando.
You folks are killing me, I have not had this much entertainment in a long time. The only thing that is different here is the company is expediently making more money than last Q and not once has vapor said anything about there MMJ/dispensary plans.. This is why I am long here. This stock will see $10 to $15 with in a year.... Mark this post...
Have a great night all and grow some balls....
ST 1.3
How I wish I had $50K right now to invest. Not sure what the catalyst is going to be to turn this but it is coming. This sector in general is going to go ape shit before to long.
ST w/ my little 1.3M going long
Medical marijuana on course for legalisation in New York
Certain forms of marijuana, administered by vaporiser or oil base, are expected to be legalised for the ill by state legislature
New York's governor Andrew Cuomo sought to ban smoking marijuana, which can be used to treat epilepsy, Aids, ALS and neuropathy. Photograph: Blair Gable/Reuters
New York is set to become the 23rd state to legalize medical marijuana under an agreement announced by legislative leaders.
The Democratic-led assembly passed the legislation 113-13 early Friday after an hour of debate.
Shortly after midnight, Senate majority leader Dean Skelos said the bill would be voted on later in the day when Republican lawmakers had reviewed the legislation.
Skelos, of Long Island, said he planned to vote for the measure and believed there were enough votes to pass the bill in the upper chamber.
The so-called Compassionate Care Act would legalize certain forms of marijuana for severely ill patients. The legislation does not allow the drug to be sold in plant form or smoked, but it can be administered through a vaporizer or in an oil base.
Earlier in the negotiations, Governor Andrew Cuomo sought to ban smoking the drug, saying it was wrong for the state to promote smoking.
"In the end you have to balance the needs of many of the patients and the truth is we're coming to a point where less and less people [sic] smoke … anyway," said bill sponsor Senator Diane Savino, a Staten Island Democrat, on Thursday.
Marijuana could be prescribed for at least 10 diseases – including epilepsy, Aids, ALS and neuropathy – under the direction of the state's health department. The health commissioner would be able to add more illnesses.
If approved by the legislature, the bill would allow the program to start in as soon as 18 months and would allow a governor to terminate it under advice from the health department or law enforcement.
"Medical marijuana has the capacity to do a lot of good for a lot of people who are in pain, who are suffering and are in desperate need of a treatment that can provide relief," Cuomo said during a news conference with lawmakers.
Doctors would have to undergo training to be eligible to prescribe the drug and could face a felony charge punishable by up to four years of prison if they write fraudulent prescriptions.
The bill does not require insurance companies to cover the cost of the drug.
Patients who sell their prescribed marijuana could face a misdemeanor charge. Patients will be required to carry registration cards showing they are authorized to possess the drug and can be prescribed a maximum 30-day supply.
Five registered growing organizations will be allowed up to four dispensaries each throughout the state, with the counties where the marijuana is grown and sold receiving revenue from an excise tax. Under the stipulation, cultivators must grow the drug indoors in a secure facility.
Cuomo was initially opposed to medical marijuana earlier in his term but proposed a pilot program in January to allow up to 20 hospitals statewide to administer the drug.
He initially wanted a five-year sunset period to evaluate the new program, but negotiations extended that to seven.
http://www.theguardian.com/world/2014/jun/20/new-york-medical-marijuana-legal-governor-cuomo
http://www.hightimes.com/read/new-york-become-23rd-medical-marijuana-state?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+HIGHTIMESMagazine+%28HIGH+TIMES+Magazine%29
Albany - Governor Cuomo held a press conference Thursday announcing that a deal had finally been reached between his office, the senate majority and the state assembly regarding medical marijuana in New York. The announcement came in the eleventh hour, after a week of negotiations that would determine the fate of patients across the state. Supporters from Brooklyn to Buffalo flooded the capitol on Wednesday to show their support for the bill. On Thursday morning behind closed doors, the leadership finally came to an agreement allowing legislation to pass this session, but not without making major sacrifices to the existing language.
Among new provisions in the bill, the most striking one does not allow traditional smoking of the flower, but would allow vaporization. Quantities are limited to two ounces per 30 days. Production facilities were scaled down from a proposed 20 to only five, but each will allowed to set up four retail locations from which to dispense product. Cuomo has gone on record saying he has wanted his state to set the model for the rest of the country by having the tightest program in the nation. New language in the bill will not only set up criminal penalties for people who try to defraud the system, but as a failsafe, will also provide a way to end the program at the governors discretion.
Early Friday morning in an overnight session, the assembly passed the bill by an overwhelming vote of 113 to 14. The senate is scheduled to resume at 10am, when they are expected to vote the bill into law before the legislative season wraps up for the year.
janice, YOU of all people know the truth to the relationship between "XYZ" companies and default swaps...........
outside non-affiliated point of observation.
DD naked shorting, fail to deliver,phantom shares, derivatives, Reg Sho, grand father clause, Credit default swaps so on and so on....
http://www.sec.gov/spotlight/keyregshoissues.htm
https://www.sec.gov/answers/nakedshortsale.htm
http://www.sec.gov/spotlight/dodd-frank/derivatives.shtml
Re: Cox: Default Swaps Are Naked Shorts September 23, 2008
Credit default swaps, potentially the next domino to fall in the ongoing financial crisis, are the debt equivalent of naked shorts on stocks, according to the chairman of the Securities and Exchange Commission.
In prepared testimony that he will deliver before the Senate Banking Committee this morning, SEC chairman Christopher Cox equated the sale of the unregulated bond derivatives with naked short selling and called on Congress to give his agency authority to regulate the derivatives.
http://ww2.cfo.com/banking-capital-markets/2008/09/cox-default-swaps-are-naked-shorts/
It is all related to Wall Street crimes against investors..................
90% of these stocks where trading in the triple 000's before they announced MMJ business. All of them where seller boxed and shorted into the abyss just waiting to DIE. (that is what the naked shorter's/Market Makers wanted) When the old margin calls started coming in and the market makers could not slow the influx of buyers, they all new they where in trouble. One company after another rose from the phoenix. There has been a few companies that have done the best they can to change the direction of these dead companies. Mergers, name change, ticker change, management change, filling past late fillings, so on and so on... When the big money (MM) started loosing there cash, the game started getting ugly. Now it is even uglier, when the MM had to call their friends at the SEC to help them, you know it must be real bad. You will probably ask if I can prove this theory and my answer will be NO, but ask the SEC what the companies (that have been suspended) did wrong and see what answer you get.. "None of your business".
So 10 days later this so called "crooked" company trades again and from there the MM and shorters are scott free all the way back to seller boxed and bankrupt... It was done in the early 2000's and has started again. The SEC is as crooked as it has always been and some things just will not change.
This is all in my observation and opinion based on my 15 years of trading.
Have a great week end folks..
May 16,2014
ST
Cannabis goes corporate: Dot-bong boom explodes as Big Marijuana flexes its muscles
ABCBy Ben Knight and Suzanne Smith | ABC – Tue, Jun 17, 2014 7:00 AM AEST
https://au.finance.yahoo.com/news/cannabis-goes-corporate-dot-bong-210029805.html
There is a new gold rush in America's west.
Decades of marijuana prohibition are coming to an end, on the back of a sea change in public opinion.
Twenty states have now voted to make the drug legal in one form or another.
Next month, Washington State will be the second state to fully legalise cannabis.
New brands and products are flooding the market, for anyone over the age of 21 to buy and consume.
Legal cannabis markets are expected to grow by 64 per cent across the United States in the next year.
Now, Wall Street is moving in.
The $40 billion black market in cannabis is going mainstream.
Hundreds of new marijuana businesses - and 2,000 existing medical marijuana sellers - are gearing up for the recreational market to take off.
The big players aim to make this an industry to rival beer.
But while there is broad public support for marijuana legalisation, opponents are ramping up the campaign to swing the pendulum back, arguing that America is creating a new Big Tobacco.
And one of that argument's chief proponents is former congressman Patrick Kennedy, the nephew of John F Kennedy and the son of senator Ted Kennedy.
Mr Kennedy has had his own battle with drugs and addiction.
Now he has formed a new organisation called SAM - Smart Approaches to Marijuana - and he is taking on big business.
"It's not about your civil liberty and your ability to smoke a joint now and again," he said.
"This is about a commercial, for-profit behemoth coming in to prey on your kids, addict them [sic] and make money off them ...
and at your expense."
'Dot-bong' era begins as Big Marijuana moves into Seattle
Seattle is Washington State's biggest city and a big business town, home to corporate giants like Boeing, Starbucks, and amazon.com.
It is also becoming the headquarters for "Big Marijuana".
Already, the state has received 7,000 applications from businesses wanting to sell recreational cannabis, and the market is being flooded with new products.
Marijuana has been fully legal in Colorado since January this year, but Seattle is where cannabis is going corporate.
The big money is rushing in.
The dot-bong era has begun.
"Interestingly, I have never used cannabis,"Â says Michael Blue, a Yale MBA graduate and entrepreneur.
The son of a surgeon, from a conservative home in Arkansas, he is probably the last person you would expect to see going into this business.
The same goes for his two partners - Christian Groh and Brendan Kennedy, another Yale MBA graduate.
Four years ago they created Privateer Holdings, the first equity company dedicated to the marijuana industry.
Brendan Kennedy was working at a Silicon Valley bank when he came up with the idea.
"We were looking for holes in the marketplace," he said.
What he saw back then were opinion polls showing that for the first time, a majority of Americans were in favour of ending the prohibition of cannabis.
Support for medical marijuana was even higher.
Eight out of 10 Americans supported marijuana for medical use.
"When we first started going into this industry we asked ourselves, morally, 'Would we feel comfortable being in the cannabis industry?'" he said.
"I'm not sure I could work in the tobacco industry.
I'm not sure I could work in the alcohol industry.Â
"But having talked to so many patients and physicians, and talked to so many activists who are interested in individual civil liberties, or patient rights - you know, we feel there's some moral imperative to succeed."
As the failures of America's war on drugs became clearer, and stories spread of cancer and epilepsy patients being helped by cannabis, state after state began putting cannabis on the ballot and voters began passing it.
But it is still a risky business.
Marijuana might be legal in 20 states, but it is still illegal under federal law. The Obama administration has essentially told federal drug authorities to look the other way.
And business is thriving.
Selling marijuana has gone way beyond simply packing ziplock plastic bags with a gram or two of dried buds.
Marijuana product range expands with hi-tech options
The marijuana industry is now hi-tech and brand-aware with electronic joints, similar to e-cigarettes, coming pre-loaded with cannabis oil promising "150 puffs guaranteed!" Marijuana-infused food products range from lollipops to nut bars to carbonated drinks.Â
Then there are electronic marijuana pens you connect via a USB port.
The waxy substance inside is 90 per cent THC - the chemical that gets you high in cannabis - one puff on this is the equivalent of a whole joint.
Â
Patrick Kennedy has enlisted president Barack Obama's former drugs adviser Kevin Sabet to his cause.
Dr Sabet is concerned about the health risks of these new products.
"They don't understand that today's marijuana can often be upwards of 90 per cent THC ...
extracted in a wax that is combusted and inhaled," he said.
"And that can often lead to emergency room admissions.
I mean for the baby boomers, [the fact] people are going to the hospital for ingesting a marijuana cookie, or one of these wax things, is totally foreign.
And yet it is the reality for a lot of kids."
Privateer stays on the right side of federal law by not buying companies that directly deal with cannabis in the US.
Its flagship buy was a website which is now the go-to domain to search and review strains of marijuana.
It took them a year to raise their first $7.4 million from wary investors.
Now, they are about to close a fundraising round of $106 million. They will not even talk to investors who do not have a least $1 million to invest.
"If you look globally, it's a $US150 billion industry," said Mr Blue.
"It will only grow as further legalisation takes place."
Fears cannabis industry will target those who can't stop
The momentum for more states to legalise seems unstoppable.
Public support is trending up but most importantly, Wall Street is moving in.
And that is what worries former US congressman Patrick Kennedy.
"What's really behind this legalisation is money, plain and simple," he said.
Patrick Kennedy is no longer in Congress.
He pulled the pin on his career in 2010 to deal with a raging addiction to alcohol and prescription drugs that at one point, saw him crash his car into a barricade outside the Capitol Building.
"It's enormously humiliating," he said.
"I would never have willingly chosen to humiliate myself and bring shame on my family, not just once, twice, three, four, five times.Â
"I mean, I have lost count of the amount of times that I said, 'Oh my God, look at what I've done to my family'."
Now married and the father of two children, he has been in recovery for four years.
Â
"Just like the liquor industry.
They don't make money off average drinkers. They make money off people like me, because I couldn't stop," he said.
"The mentally ill, or those who have predisposition for addiction and alcoholism ... they are really the candidates that the Big Marijuana industry is targeting.
"You capture an addiction, you've got a customer."
He is out to spread the message that cannabis is more addictive than people realise, far more potent than it used to be, and a danger to people at risk of mental illness.
But he has a hell of a task in front of him.Â
The fact is, plenty of Americans enjoy using cannabis and while a certain proportion become addicted, many find it does not ruin their lives.Â
And they have years of their own experience of doing it illegally to draw on.
Cannabis retailer campaigns for end to prohibition
John Davis, who put the money he earned from his career in construction into shops selling cannabis to the public, says the drug is not harmful.Â
"This is not dangerous.
I have smoked this marijuana," he told the ABC at his dispensary in West Seattle.
"It didn't give me homicidal urges.
Right? It made me enjoy a movie."
Unlike the Ivy League crew at Privateer, Mr Davis deals directly in cannabis.
And under federal law, that means he is risking serious prison time, but he says somebody has to do it in order to end marijuana prohibition for good.
"Look, Patrick Kennedy had a severe drug problem.
That doesn't make him a policy expert," Mr Davis said.
"We have the highest prison population of any other civilisation in the history of civilisation.
"We jail people at an astonishing rate.
For what? For drugs. Does that help the drug problem? Because it doesn't make the drugs go away."
Lobbyist hired to push pot's cause on Capitol Hill
But the battle is not being played out in Mr Davis' marijuana dispensary in Seattle. It is in Washington DC.
Because cannabis is still illegal under federal law, the cannabis industry is locked out of the banking system. The entire multi-million-dollar business operates in cash.
So the industry has hired a lobbyist to try to convince federal lawmakers to change the regulations.
Patrick Kennedy says if that happens, the money spigot will be opened up, and it will be all but impossible to turn off again.
"When you have those kinds of profits, you can saturate the political system.
And most importantly, you can saturate the airwaves with your message," he said.
"It basically took 50 years before you got the political will to change our policy around allowing tobacco companies to market their product with impunity. So let's use that as a case study."
The US Congress - and the rest of the country â?? will be watching the Denver and Seattle experiments closely, but Mr Davis says there is no going back.
"The wall is falling, and everyone sees it," he said.
"And everyone's astonished.
But it doesn't stop."Â
"The end of prohibition is now, because prohibition is a bankrupt policy that doesn't work."
Patrick Kennedy says those who currently say they support legalisation have not been told what it means in practice.
"I think what's going to turn the American people off is less the notion of marijuana - although that's going to be a big factor - than the notion that you're going to have this big commercial, big money, corporation."
"There are definitely going to be consumers, and a good percentage of them are never going to leave you.Â
"Well, if you're an industry ...
I mean that's just like you've hit the jackpot."
Watch Foreign Correspondent's report Cannabis Inc on ABC 1 at 8:00pm.
Cannabis goes corporate: Dot-bong boom explodes as Big Marijuana flexes its muscles
ABCBy Ben Knight and Suzanne Smith | ABC – Tue, Jun 17, 2014 7:00 AM AEST
https://au.finance.yahoo.com/news/cannabis-goes-corporate-dot-bong-210029805.html
There is a new gold rush in America's west.
Decades of marijuana prohibition are coming to an end, on the back of a sea change in public opinion.
Twenty states have now voted to make the drug legal in one form or another.
Next month, Washington State will be the second state to fully legalise cannabis.
New brands and products are flooding the market, for anyone over the age of 21 to buy and consume.
Legal cannabis markets are expected to grow by 64 per cent across the United States in the next year.
Now, Wall Street is moving in.
The $40 billion black market in cannabis is going mainstream.
Hundreds of new marijuana businesses - and 2,000 existing medical marijuana sellers - are gearing up for the recreational market to take off.
The big players aim to make this an industry to rival beer.
But while there is broad public support for marijuana legalisation, opponents are ramping up the campaign to swing the pendulum back, arguing that America is creating a new Big Tobacco.
And one of that argument's chief proponents is former congressman Patrick Kennedy, the nephew of John F Kennedy and the son of senator Ted Kennedy.
Mr Kennedy has had his own battle with drugs and addiction.
Now he has formed a new organisation called SAM - Smart Approaches to Marijuana - and he is taking on big business.
"It's not about your civil liberty and your ability to smoke a joint now and again," he said.
"This is about a commercial, for-profit behemoth coming in to prey on your kids, addict them [sic] and make money off them ...
and at your expense."
'Dot-bong' era begins as Big Marijuana moves into Seattle
Seattle is Washington State's biggest city and a big business town, home to corporate giants like Boeing, Starbucks, and amazon.com.
It is also becoming the headquarters for "Big Marijuana".
Already, the state has received 7,000 applications from businesses wanting to sell recreational cannabis, and the market is being flooded with new products.
Marijuana has been fully legal in Colorado since January this year, but Seattle is where cannabis is going corporate.
The big money is rushing in.
The dot-bong era has begun.
"Interestingly, I have never used cannabis,"Â says Michael Blue, a Yale MBA graduate and entrepreneur.
The son of a surgeon, from a conservative home in Arkansas, he is probably the last person you would expect to see going into this business.
The same goes for his two partners - Christian Groh and Brendan Kennedy, another Yale MBA graduate.
Four years ago they created Privateer Holdings, the first equity company dedicated to the marijuana industry.
Brendan Kennedy was working at a Silicon Valley bank when he came up with the idea.
"We were looking for holes in the marketplace," he said.
What he saw back then were opinion polls showing that for the first time, a majority of Americans were in favour of ending the prohibition of cannabis.
Support for medical marijuana was even higher.
Eight out of 10 Americans supported marijuana for medical use.
"When we first started going into this industry we asked ourselves, morally, 'Would we feel comfortable being in the cannabis industry?'" he said.
"I'm not sure I could work in the tobacco industry.
I'm not sure I could work in the alcohol industry.Â
"But having talked to so many patients and physicians, and talked to so many activists who are interested in individual civil liberties, or patient rights - you know, we feel there's some moral imperative to succeed."
As the failures of America's war on drugs became clearer, and stories spread of cancer and epilepsy patients being helped by cannabis, state after state began putting cannabis on the ballot and voters began passing it.
But it is still a risky business.
Marijuana might be legal in 20 states, but it is still illegal under federal law. The Obama administration has essentially told federal drug authorities to look the other way.
And business is thriving.
Selling marijuana has gone way beyond simply packing ziplock plastic bags with a gram or two of dried buds.
Marijuana product range expands with hi-tech options
The marijuana industry is now hi-tech and brand-aware with electronic joints, similar to e-cigarettes, coming pre-loaded with cannabis oil promising "150 puffs guaranteed!" Marijuana-infused food products range from lollipops to nut bars to carbonated drinks.Â
Then there are electronic marijuana pens you connect via a USB port.
The waxy substance inside is 90 per cent THC - the chemical that gets you high in cannabis - one puff on this is the equivalent of a whole joint.
Â
Patrick Kennedy has enlisted president Barack Obama's former drugs adviser Kevin Sabet to his cause.
Dr Sabet is concerned about the health risks of these new products.
"They don't understand that today's marijuana can often be upwards of 90 per cent THC ...
extracted in a wax that is combusted and inhaled," he said.
"And that can often lead to emergency room admissions.
I mean for the baby boomers, [the fact] people are going to the hospital for ingesting a marijuana cookie, or one of these wax things, is totally foreign.
And yet it is the reality for a lot of kids."
Privateer stays on the right side of federal law by not buying companies that directly deal with cannabis in the US.
Its flagship buy was a website which is now the go-to domain to search and review strains of marijuana.
It took them a year to raise their first $7.4 million from wary investors.
Now, they are about to close a fundraising round of $106 million. They will not even talk to investors who do not have a least $1 million to invest.
"If you look globally, it's a $US150 billion industry," said Mr Blue.
"It will only grow as further legalisation takes place."
Fears cannabis industry will target those who can't stop
The momentum for more states to legalise seems unstoppable.
Public support is trending up but most importantly, Wall Street is moving in.
And that is what worries former US congressman Patrick Kennedy.
"What's really behind this legalisation is money, plain and simple," he said.
Patrick Kennedy is no longer in Congress.
He pulled the pin on his career in 2010 to deal with a raging addiction to alcohol and prescription drugs that at one point, saw him crash his car into a barricade outside the Capitol Building.
"It's enormously humiliating," he said.
"I would never have willingly chosen to humiliate myself and bring shame on my family, not just once, twice, three, four, five times.Â
"I mean, I have lost count of the amount of times that I said, 'Oh my God, look at what I've done to my family'."
Now married and the father of two children, he has been in recovery for four years.
Â
"Just like the liquor industry.
They don't make money off average drinkers. They make money off people like me, because I couldn't stop," he said.
"The mentally ill, or those who have predisposition for addiction and alcoholism ... they are really the candidates that the Big Marijuana industry is targeting.
"You capture an addiction, you've got a customer."
He is out to spread the message that cannabis is more addictive than people realise, far more potent than it used to be, and a danger to people at risk of mental illness.
But he has a hell of a task in front of him.Â
The fact is, plenty of Americans enjoy using cannabis and while a certain proportion become addicted, many find it does not ruin their lives.Â
And they have years of their own experience of doing it illegally to draw on.
Cannabis retailer campaigns for end to prohibition
John Davis, who put the money he earned from his career in construction into shops selling cannabis to the public, says the drug is not harmful.Â
"This is not dangerous.
I have smoked this marijuana," he told the ABC at his dispensary in West Seattle.
"It didn't give me homicidal urges.
Right? It made me enjoy a movie."
Unlike the Ivy League crew at Privateer, Mr Davis deals directly in cannabis.
And under federal law, that means he is risking serious prison time, but he says somebody has to do it in order to end marijuana prohibition for good.
"Look, Patrick Kennedy had a severe drug problem.
That doesn't make him a policy expert," Mr Davis said.
"We have the highest prison population of any other civilisation in the history of civilisation.
"We jail people at an astonishing rate.
For what? For drugs. Does that help the drug problem? Because it doesn't make the drugs go away."
Lobbyist hired to push pot's cause on Capitol Hill
But the battle is not being played out in Mr Davis' marijuana dispensary in Seattle. It is in Washington DC.
Because cannabis is still illegal under federal law, the cannabis industry is locked out of the banking system. The entire multi-million-dollar business operates in cash.
So the industry has hired a lobbyist to try to convince federal lawmakers to change the regulations.
Patrick Kennedy says if that happens, the money spigot will be opened up, and it will be all but impossible to turn off again.
"When you have those kinds of profits, you can saturate the political system.
And most importantly, you can saturate the airwaves with your message," he said.
"It basically took 50 years before you got the political will to change our policy around allowing tobacco companies to market their product with impunity. So let's use that as a case study."
The US Congress - and the rest of the country â?? will be watching the Denver and Seattle experiments closely, but Mr Davis says there is no going back.
"The wall is falling, and everyone sees it," he said.
"And everyone's astonished.
But it doesn't stop."Â
"The end of prohibition is now, because prohibition is a bankrupt policy that doesn't work."
Patrick Kennedy says those who currently say they support legalisation have not been told what it means in practice.
"I think what's going to turn the American people off is less the notion of marijuana - although that's going to be a big factor - than the notion that you're going to have this big commercial, big money, corporation."
"There are definitely going to be consumers, and a good percentage of them are never going to leave you.Â
"Well, if you're an industry ...
I mean that's just like you've hit the jackpot."
Watch Foreign Correspondent's report Cannabis Inc on ABC 1 at 8:00pm.
need a push right now. .0043 has to go.................
Medical Marijuana Sector Could Exceed $8 Billion
in Revenue
Need to push threw the .0043 now or return back to the 3's slap the ask
Weedstock Cannabis Investor Conference, Denver, Colorado, June 29-July 1, 2014
http://www.weedstockconference.com/presenters.html
Don't forget folks Weedstock Cannabis Investor Conference at end of month. I am Friken EXCITED about Vapor Groups future and mine.
Look at the list so far,
http://www.weedstockconference.com/presenters.html
8:15a ET June 11, 2014 (Market Wire) Print
Vapor Group, Inc., VPOR, to Attend Weedstock Cannabis Investor Conference, Denver, Colorado, June 29-July 1, 2014 and Introduce Revolutionary Line of New Vaporizers
Vapor Group, Inc., (OTCQB: VPOR), (the "Company", "Vapor Group"), announced today that it would attend the Weedstock Cannabis Investor Conference being held at the Westin Denver Downtown Hotel, Denver, Colorado, June 29th-July 1st, at which it will introduce a new line of high-end, sophisticated vaporizers.
Yaniv Nahon, Chief Operating Officer, said, "Clearly an important and growing sector of our industry is the emerging cannabis marketplace. As an industry leader, this conference is important to us because it gives us the opportunity to showcase our new technologies. At this conference we will showcase several revolutionary and very exciting new products:
Our recently announced "Vapor Box THB" dry herb vaporizer that redefines the standard for all herb vaporizers sold today by vaporizing dry herbs and oil-wax by gently heating them with pure, heated air inside the heating chamber at a controlled temperature which is set to optimally vaporize an herb without burning it, as occurs with current vaporizers that all use heating coils. Using this new vaporization technique, the Vapor Box THB delivers consistent vapor puff after puff, without the eventual burnt taste caused by harsh chemicals generated by combustion. It is truly a sophisticated breakthrough in how vaporizers work! And, it has been designed to sustain a 10,000 hour work life.
The unbelievable and fun, multifunctional "VAPOD" -- rugged, durable, water and shock resistant, that accepts variable voltage and wattage and has a standard 510/ego connection -- it can even charge your cell phone and USB devices!
The highly exciting and revolutionary NEW Triple 3 Atomizer which come with 3 coils -- one each for e-liquid, dry herb and oil-wax! The tank size is a huge 5 milliliter, constructed from heavy gauge stainless steel which has been designed to handle high heat. The high quality coils at the bottom of the chamber can be changed out for whatever your smoking preference may be. When activated, each coil will quickly heat up your e-liquid, dry herbs or oil-wax concentrates and releases their vapors. The chamber is extremely easy to fill and clean and is quite durable. The Triple 3 Atomizer Kit includes the Atomizer, a glass tank and special coils for heating e-liquids, herbs, oil and wax.
In the end, these products represent the cutting edge of our industry. Today, it doesn't get any better than that."
About the Weedstock Cannabis Investor Conference The objective of the 2014 Weedstock Cannabis Investor Conference is to connect privately held and publicly traded companies in the cannabis industry with industry investors, and analysts. The Conference will include exhibits and presentations by industry participants including growers, dispensaries, and suppliers and consultants. The conference will also feature panel discussions and facilitate one-on-one meetings and networking opportunities for those attending. More detailed information may be obtained at http://weedstockconference.com.
About the Vapor Group Vapor Group, Inc., www.vaporgroup.com, is in the business of designing, developing, manufacturing and marketing high quality, vaporizers and e-cigarette brands which use state-of-the-art electronic technology and specially formulated, "Made in the USA" e-liquids, which may or may not contain nicotine. It offers a range of products with unique e-liquid flavors that is unmatched in our industry. Its products are marketed under the Vapor Group, Total Vapor, Vapor 123, American Smoke and Vapor Products brands. It sells nationwide through distributors, wholesalers and directly to consumers through its own websites and direct response advertising.
All of its E-cigarettes consist of a long-life battery, a heating element, a cartridge filled with an "e-liquid" and an atomizer which when heated, vaporizes the e-liquid. Because E-cigarettes are not "lit" like regular cigarettes, they don't create flame, smoke from burning, ash, tar, noxious fumes or leftover "cigarette butts". As a result, they may be used virtually anywhere. Vapor Group is committed to providing E-cigarettes that are convenient and economical to use, safer and healthier than traditional smoking, and which provide a flavorful, enjoyable smoking experience.
Vapor Group, Inc. is managed by a highly experienced team of executives committed to responsible business policies and practices, including the marketing of our products only to those eighteen years of age or older, not making or avoiding claims about our product health benefits, and fulfilling the requirements of all applicable laws and regulations.
Safe Harbor Statement: This release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate", "project", "intend", "forecast", "anticipate", "plan", "planning", "expect", "believe", "will likely", "should", "could", "would", "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- activities of competitors and the presence of new or additional competition and conditions of equity markets.
CONTACT:
Vapor Group, Inc.
954-792-8450
SOURCE: Vapor Group, Inc.
A last 10 min. run into the 7 would be nice to see or at least close at HOD
ST
Chart is shaping up for a breakout. Very nice to see.
ST 1.3 long SweeeeeetWeeeeeed
What blatant manipulation the last 5 min.. SLNX should run hard tomorrow.
porky, since Jan.22, 2014 Vapor has done every thing they said they would.
I have no real concerns of them executing there business plan already publicly known, even if it is not on our timing, I truly believe it will happen. There is definitely things we don't know of future plans and that is what gets me so friken EXCITED. Both sectors (E-cig/MMJ) are new and billions have not even been taped into yet. Vapor will continue tapping into a small percentage at a time of these new markets in the next few years and make quite a few people very very wealthy financially..
Remember:
Florida votes in November (MMJ) and 4 or 5 other states too. Open as many Vapor store fronts (aka dispensaries) as possible by years end and be ready to cover both markets. $$$$$$$ I hope to see a PR like that by end of year.
All IMO only
ST 1.3
LYN, as long as we close over the 200MA then no worries then mate. Every top finds a bottom. Charting is not perfect especially in this sector.
ST 1.3
Only 93.2M in float and no selling, Vapor is going to run hard when it runs...... lol
ST 1.3 who is going to be the other 92 millionaires?